Annual CFO:
$595.40M+$205.50M(+52.71%)Summary
- As of today, NBIX annual cash from operations is $595.40 million, with the most recent change of +$205.50 million (+52.71%) on December 31, 2024.
- During the last 3 years, NBIX annual cash from operations has risen by +$338.90 million (+132.12%).
- NBIX annual cash from operations is now at all-time high.
Performance
NBIX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$102.00M+$37.20M(+57.41%)Summary
- As of today, NBIX quarterly cash from operations is $102.00 million, with the most recent change of +$37.20 million (+57.41%) on June 30, 2025.
- Over the past year, NBIX quarterly cash from operations has increased by +$37.40 million (+57.89%).
- NBIX quarterly cash from operations is now -57.94% below its all-time high of $242.50 million, reached on December 31, 2024.
Performance
NBIX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$567.30M+$37.40M(+7.06%)Summary
- As of today, NBIX TTM cash from operations is $567.30 million, with the most recent change of +$37.40 million (+7.06%) on June 30, 2025.
- Over the past year, NBIX TTM cash from operations has increased by +$36.90 million (+6.96%).
- NBIX TTM cash from operations is now -12.10% below its all-time high of $645.40 million, reached on March 31, 2024.
Performance
NBIX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NBIX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +52.7% | +57.9% | +7.0% |
| 3Y3 Years | +132.1% | -26.1% | +246.8% |
| 5Y5 Years | +305.0% | -14.2% | +145.1% |
NBIX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +132.1% | -57.9% | +181.5% | -12.1% | +182.8% |
| 5Y | 5-Year | at high | +305.0% | -57.9% | +181.5% | -12.1% | +340.8% |
| All-Time | All-Time | at high | +660.7% | -57.9% | +181.5% | -12.1% | +401.4% |
NBIX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $102.00M(+57.4%) | $567.30M(+7.1%) |
| Mar 2025 | - | $64.80M(-73.3%) | $529.90M(-11.0%) |
| Dec 2024 | $595.40M(+52.7%) | $242.50M(+53.5%) | $595.40M(+25.0%) |
| Sep 2024 | - | $158.00M(+144.6%) | $476.40M(-10.2%) |
| Jun 2024 | - | $64.60M(-50.4%) | $530.40M(-17.8%) |
| Mar 2024 | - | $130.30M(+5.5%) | $645.40M(+65.5%) |
| Dec 2023 | $389.90M(+14.9%) | $123.50M(-41.7%) | $389.90M(-4.8%) |
| Sep 2023 | - | $212.00M(+18.0%) | $409.40M(+38.2%) |
| Jun 2023 | - | $179.60M(+243.5%) | $296.20M(+16.3%) |
| Mar 2023 | - | -$125.20M(-187.6%) | $254.70M(-25.0%) |
| Dec 2022 | $339.40M(+32.3%) | $143.00M(+44.7%) | $339.40M(+69.2%) |
| Sep 2022 | - | $98.80M(-28.5%) | $200.60M(+22.6%) |
| Jun 2022 | - | $138.10M(+441.0%) | $163.60M(+27.1%) |
| Mar 2022 | - | -$40.50M(-1064.3%) | $128.70M(-49.8%) |
| Dec 2021 | $256.50M(+12.3%) | $4.20M(-93.2%) | $256.50M(-26.0%) |
| Sep 2021 | - | $61.80M(-40.1%) | $346.80M(+31.1%) |
| Jun 2021 | - | $103.20M(+18.2%) | $264.60M(-5.6%) |
| Mar 2021 | - | $87.30M(-7.6%) | $280.30M(+22.7%) |
| Dec 2020 | $228.50M(+55.4%) | $94.50M(+563.2%) | $228.50M(-1.3%) |
| Sep 2020 | - | -$20.40M(-117.2%) | $231.50M(-33.8%) |
| Jun 2020 | - | $118.90M(+234.9%) | $349.70M(+18.5%) |
| Mar 2020 | - | $35.50M(-63.6%) | $295.00M(+100.7%) |
| Dec 2019 | $147.00M(+45.0%) | $97.50M(-0.3%) | $147.00M(+47.0%) |
| Sep 2019 | - | $97.80M(+52.3%) | $99.99M(+40.6%) |
| Jun 2019 | - | $64.20M(+157.1%) | $71.11M(+159.6%) |
| Mar 2019 | - | -$112.50M(-322.8%) | $27.39M(-73.0%) |
| Dec 2018 | $101.40M(+207.5%) | $50.49M(-26.7%) | $101.40M(+10.8%) |
| Sep 2018 | - | $68.92M(+236.5%) | $91.48M(+590.0%) |
| Jun 2018 | - | $20.48M(+153.2%) | $13.26M(+123.9%) |
| Mar 2018 | - | -$38.49M(-194.9%) | -$55.46M(+41.2%) |
| Dec 2017 | -$94.33M(+11.2%) | $40.58M(+535.8%) | -$94.33M(+43.4%) |
| Sep 2017 | - | -$9.31M(+80.7%) | -$166.53M(+11.5%) |
| Jun 2017 | - | -$48.24M(+37.6%) | -$188.23M(-22.0%) |
| Mar 2017 | - | -$77.36M(-144.6%) | -$154.33M(-45.3%) |
| Dec 2016 | -$106.18M(-179.4%) | -$31.63M(-2.0%) | -$106.18M(-18.3%) |
| Sep 2016 | - | -$31.01M(-116.3%) | -$89.76M(-16.1%) |
| Jun 2016 | - | -$14.34M(+50.9%) | -$77.32M(-57.7%) |
| Mar 2016 | - | -$29.21M(-92.1%) | -$49.02M(-29.0%) |
| Dec 2015 | -$38.00M(+19.4%) | -$15.20M(+18.1%) | -$38.00M(+0.3%) |
| Sep 2015 | - | -$18.57M(-233.0%) | -$38.10M(-20.5%) |
| Jun 2015 | - | $13.96M(+176.8%) | -$31.63M(+43.1%) |
| Mar 2015 | - | -$18.18M(-18.8%) | -$55.56M(-17.9%) |
| Dec 2014 | -$47.14M(-59.2%) | -$15.31M(-26.5%) | -$47.14M(-10.4%) |
| Sep 2014 | - | -$12.10M(-21.4%) | -$42.71M(-3.2%) |
| Jun 2014 | - | -$9.96M(-2.0%) | -$41.39M(-0.3%) |
| Mar 2014 | - | -$9.77M(+10.2%) | -$41.29M(-39.4%) |
| Dec 2013 | -$29.61M(+16.1%) | -$10.88M(-0.9%) | -$29.61M(-7.1%) |
| Sep 2013 | - | -$10.78M(-9.3%) | -$27.64M(-9.8%) |
| Jun 2013 | - | -$9.86M(-615.7%) | -$25.16M(-13.4%) |
| Mar 2013 | - | $1.91M(+121.5%) | -$22.18M(+37.2%) |
| Dec 2012 | -$35.29M(-4956.4%) | -$8.91M(-7.3%) | -$35.29M(-129.7%) |
| Sep 2012 | - | -$8.30M(-20.7%) | -$15.37M(-258.2%) |
| Jun 2012 | - | -$6.88M(+38.6%) | -$4.29M(-29.1%) |
| Mar 2012 | - | -$11.20M(-201.7%) | -$3.32M(-375.9%) |
| Dec 2011 | -$698.00K(-101.4%) | $11.02M(+297.5%) | -$698.00K(+95.7%) |
| Sep 2011 | - | $2.77M(+146.9%) | -$16.25M(+9.1%) |
| Jun 2011 | - | -$5.91M(+31.1%) | -$17.88M(-133.4%) |
| Mar 2011 | - | -$8.58M(-89.5%) | $53.55M(+7.2%) |
| Dec 2010 | $49.94M | -$4.53M(-496.8%) | $49.94M(+23.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $1.14M(-98.3%) | $40.50M(+43.3%) |
| Jun 2010 | - | $65.52M(+637.6%) | $28.26M(+155.5%) |
| Mar 2010 | - | -$12.19M(+12.8%) | -$50.89M(+4.1%) |
| Dec 2009 | -$53.09M(+28.4%) | -$13.97M(-25.9%) | -$53.09M(+4.2%) |
| Sep 2009 | - | -$11.10M(+18.6%) | -$55.41M(+6.1%) |
| Jun 2009 | - | -$13.63M(+5.3%) | -$59.01M(+2.3%) |
| Mar 2009 | - | -$14.39M(+11.7%) | -$60.39M(+18.6%) |
| Dec 2008 | -$74.17M(-25.0%) | -$16.29M(-10.9%) | -$74.17M(-19.4%) |
| Sep 2008 | - | -$14.70M(+2.1%) | -$62.10M(+9.9%) |
| Jun 2008 | - | -$15.01M(+46.7%) | -$68.91M(+5.2%) |
| Mar 2008 | - | -$28.17M(-566.5%) | -$72.65M(-22.4%) |
| Dec 2007 | -$59.33M(+40.3%) | -$4.23M(+80.3%) | -$59.33M(+17.5%) |
| Sep 2007 | - | -$21.50M(-14.6%) | -$71.91M(+14.5%) |
| Jun 2007 | - | -$18.75M(-26.3%) | -$84.15M(+10.3%) |
| Mar 2007 | - | -$14.85M(+11.6%) | -$93.84M(+5.5%) |
| Dec 2006 | -$99.33M(-222.6%) | -$16.80M(+50.2%) | -$99.33M(+5.8%) |
| Sep 2006 | - | -$33.74M(-18.6%) | -$105.44M(-304.0%) |
| Jun 2006 | - | -$28.44M(-39.8%) | -$26.10M(-3.7%) |
| Mar 2006 | - | -$20.35M(+11.2%) | -$25.16M(+18.3%) |
| Dec 2005 | -$30.79M(+69.2%) | -$22.90M(-150.2%) | -$30.79M(+16.7%) |
| Sep 2005 | - | $45.60M(+265.8%) | -$36.95M(+58.7%) |
| Jun 2005 | - | -$27.51M(-5.9%) | -$89.43M(+11.9%) |
| Mar 2005 | - | -$25.98M(+10.6%) | -$101.47M(-1.5%) |
| Dec 2004 | -$99.99M(-369.3%) | -$29.06M(-322.0%) | -$99.99M(-37.8%) |
| Sep 2004 | - | -$6.88M(+82.6%) | -$72.57M(-0.7%) |
| Jun 2004 | - | -$39.55M(-61.5%) | -$72.06M(-43.6%) |
| Mar 2004 | - | -$24.49M(-1391.6%) | -$50.18M(-235.2%) |
| Dec 2003 | $37.13M(+146.8%) | -$1.64M(+74.2%) | $37.13M(+520.6%) |
| Sep 2003 | - | -$6.38M(+63.9%) | $5.98M(+354.9%) |
| Jun 2003 | - | -$17.67M(-128.1%) | -$2.35M(+47.3%) |
| Mar 2003 | - | $62.82M(+291.6%) | -$4.45M(+94.4%) |
| Dec 2002 | -$79.36M(-263.1%) | -$32.79M(-123.0%) | -$79.36M(-70.7%) |
| Sep 2002 | - | -$14.71M(+25.7%) | -$46.49M(-40.5%) |
| Jun 2002 | - | -$19.78M(-63.6%) | -$33.09M(-28.6%) |
| Mar 2002 | - | -$12.09M(>-9900.0%) | -$25.73M(-17.7%) |
| Dec 2001 | -$21.86M(-17.2%) | $91.00K(+107.0%) | -$21.86M(+21.3%) |
| Sep 2001 | - | -$1.30M(+89.5%) | -$27.77M(+2.6%) |
| Jun 2001 | - | -$12.43M(-51.2%) | -$28.52M(-14.6%) |
| Mar 2001 | - | -$8.22M(-41.2%) | -$24.90M(-33.5%) |
| Dec 2000 | -$18.64M(-81.0%) | -$5.82M(-183.3%) | -$18.64M(-73.9%) |
| Sep 2000 | - | -$2.06M(+76.7%) | -$10.72M(+14.0%) |
| Jun 2000 | - | -$8.80M(-348.0%) | -$12.47M(-50.9%) |
| Mar 2000 | - | -$1.97M(-193.6%) | -$8.27M(+19.8%) |
| Dec 1999 | -$10.30M(+3.7%) | $2.10M(+155.3%) | -$10.30M(+31.8%) |
| Sep 1999 | - | -$3.80M(+17.4%) | -$15.10M(-31.3%) |
| Jun 1999 | - | -$4.60M(-15.0%) | -$11.50M(-27.8%) |
| Mar 1999 | - | -$4.00M(-48.1%) | -$9.00M(+15.9%) |
| Dec 1998 | -$10.70M(-197.3%) | -$2.70M(-1250.0%) | -$10.70M(-813.3%) |
| Sep 1998 | - | -$200.00K(+90.5%) | $1.50M(-78.6%) |
| Jun 1998 | - | -$2.10M(+63.2%) | $7.00M(+133.3%) |
| Mar 1998 | - | -$5.70M(-160.0%) | $3.00M(-72.7%) |
| Dec 1997 | $11.00M(+64.2%) | $9.50M(+79.2%) | $11.00M(-4.3%) |
| Sep 1997 | - | $5.30M(+186.9%) | $11.50M(+105.4%) |
| Jun 1997 | - | -$6.10M(-365.2%) | $5.60M(-51.7%) |
| Mar 1997 | - | $2.30M(-77.0%) | $11.60M(+73.1%) |
| Dec 1996 | $6.70M | $10.00M(+1766.7%) | $6.70M(+303.0%) |
| Sep 1996 | - | -$600.00K(-500.0%) | -$3.30M(-22.2%) |
| Jun 1996 | - | -$100.00K(+96.2%) | -$2.70M(-3.8%) |
| Mar 1996 | - | -$2.60M | -$2.60M |
FAQ
- What is Neurocrine Biosciences, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. annual cash from operations year-on-year change?
- What is Neurocrine Biosciences, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. quarterly cash from operations year-on-year change?
- What is Neurocrine Biosciences, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. TTM cash from operations year-on-year change?
What is Neurocrine Biosciences, Inc. annual cash from operations?
The current annual cash from operations of NBIX is $595.40M
What is the all-time high annual cash from operations for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high annual cash from operations is $595.40M
What is Neurocrine Biosciences, Inc. annual cash from operations year-on-year change?
Over the past year, NBIX annual cash from operations has changed by +$205.50M (+52.71%)
What is Neurocrine Biosciences, Inc. quarterly cash from operations?
The current quarterly cash from operations of NBIX is $102.00M
What is the all-time high quarterly cash from operations for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high quarterly cash from operations is $242.50M
What is Neurocrine Biosciences, Inc. quarterly cash from operations year-on-year change?
Over the past year, NBIX quarterly cash from operations has changed by +$37.40M (+57.89%)
What is Neurocrine Biosciences, Inc. TTM cash from operations?
The current TTM cash from operations of NBIX is $567.30M
What is the all-time high TTM cash from operations for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high TTM cash from operations is $645.40M
What is Neurocrine Biosciences, Inc. TTM cash from operations year-on-year change?
Over the past year, NBIX TTM cash from operations has changed by +$36.90M (+6.96%)